Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Takeda's Atacand scheduled for European launch later this year

July 22, 1997

Low-dose diuretic prevents heart failure in the elderly

July 21, 1997

Selective 15-LO inhibitor effective in animal model of atherosclerosis

July 18, 1997

Orally active ET antagonist from BMS in clinical trials

July 18, 1997

Nippon Shinyaku reveals new series of carboxylic acid derivatives

July 18, 1997

Yamanouchi discloses Na+/H+-exchange inhibitors for cardiovascular indications

July 18, 1997

Agents for increasing HDL cholesterol from American Home Products

July 18, 1997

Zambon develops dual ACE/NEP inhibitors

July 18, 1997

New cardiovascular drugs reported by Yamanouchi

July 17, 1997

Kanebo reports novel cell adhesion inhibitors

July 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...